Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

Publication Type:

Journal Article


Gynecologic oncology, Volume 116, Issue 3, p.378-83 (2010)


2010, CA-125 Antigen, Case-Control Studies, Center-Authored Paper, Clinical Research Division, Epididymal Secretory Proteins, Female, Humans, Logistic Models, Middle Aged, Ovarian Neoplasms, Predictive Value of Tests, Prospective Studies, Severity of Illness Index, Shared Resources, Specimen Processing Core Facility


Prior studies suggest that combining the Symptom Index (SI) with a serum HE4 test or a CA125 test may improve prediction of ovarian cancer. However, these three tests have not been evaluated in combination.